Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
JPB Capital Partners is a private equity firm headquartered in Columbia, Maryland, that specializes in investments in lower middle-market companies. The firm manages several investment vehicles, including JPB Capital Partners II, which focuses on buyouts, recapitalizations, and growth capital for businesses in the Mid-Atlantic and Southeast United States. While a generalist investor, JPB maintains a significant focus on the healthcare and life sciences sectors, targeting companies with revenues between $20 million and $200 million. Notable healthcare-related investments in their portfolio have included Bio-Nucleonics, a radiopharmaceutical company, and Noxilizer, a provider of nitrogen dioxide sterilization technology for medical devices. The firm leverages its operational expertise to partner with management teams to drive long-term value and operational excellence.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on JPB Capital Partners II.